ArticleDisease markers2020

Identification of PDL1-Related Biomarkers to Select Lung Adenocarcinoma Patients for PD1/PDL1 Inhibitors.

Yanping Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.